During the past decade, Medical Center Convex EOOD conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Center Convex EOOD" #1 sponsor was "Shire" with 5 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "A. Vogel AG" with 3 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Center Convex EOOD" #1 collaborator was "Biodome Clinical" with 2 trials as a collaborator, "MediStat Ltd." with 2 trials as a collaborator, "Bodimed" with 1 trials as a collaborator, "CONVEX CRO" with 1 trials as a collaborator and "Clinical Research Centre CONVEX" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Medical Center Convex EOOD" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (3 trials), "Arthritis, Psoriatic" (1 trials), "COVID-19 Respiratory Infection" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Medical Center Convex EOOD" in a lesser frequency.

Most popular intervention types in "Medical Center Convex EOOD" are "Drug" (13 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ontamalimab" (4 trials), "Echinaforce Chewable tablets" (2 trials), "Guselkumab" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center Convex EOOD" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Medical Center Convex EOOD". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Medical Center Convex EOOD, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center Convex EOOD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".